Adaptive Biotechnologies (ADPT) P/E (2019 - 2026)
Adaptive Biotechnologies (ADPT) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM Adaptive Biotechnologies (ADPT) P/E is -70.70. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Adaptive Biotechnologies (ADPT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -70.70 | +69.98% |
| 2025 | -41.59 | +650.12% |
| 2024 | -5.55 | +53.71% |
| 2023 | -3.61 | -26.49% |
| 2022 | -4.91 | -74.26% |
| 2021 | -19.06 | -64.45% |
| 2020 | -53.63 | -50.39% |
| 2019 | -108.10 | N/A |
Comparison Adaptive Biotechnologies (ADPT) P/E with competitors
Adaptive Biotechnologies (ADPT) P/E is -70.70.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -101.48% |
| MBAI | CheckCap Ltd | 1.71 | -102.42% |
| FONR | Fonar Corp | 15.48 | -121.89% |
| QGEN | Qiagen NV | 20.03 | -128.33% |
| DGX | Quest Diagnostics Inc | 22.47 | -131.79% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -133.76% |
| IQV | IQVIA Holdings Inc | 25.28 | -135.76% |
| A | Agilent Technologies Inc | 26.96 | -138.13% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -144.59% |
| MTD | Mettler-Toledo International Inc | 32.45 | -145.90% |
| MEDP | Medpace Holdings Inc | 32.55 | -146.04% |
| DHR | Danaher Corp | 38.55 | -154.53% |
| IDXX | Idexx Laboratories Inc | 40.58 | -157.39% |
| ILMN | Illumina Inc | 44.12 | -162.40% |
| RVTY | Revvity Inc | 52.68 | -174.51% |
| VCYT | Veracyte Inc | 53.71 | -175.97% |
| ICLR | Icon Plc | 57.45 | -181.26% |
| SHC | Sotera Health Company | 74.08 | -204.78% |
| WAT | Waters Corp | 102.79 | -245.38% |